1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
We search for our client, Adualys Therapeutics, a Consultant Translational Medicine Leader. In this role, you will drive in alignment with the CMO the overall translational strategy across solid tumor oncology programs and contribute to the
Recommended jobs for you
